The global injectable drug delivery market is growing around 11.8% CAGR and will soon eclipse oral delivery as the most valuable route of administration of pharmaceuticals. The market was valued at $328 million in 2015 and is expected to reach $640 million by 2021. This growth is being fueled by biologics, which are expected to grow at a clip of 26.5% to over $250 billion by 2020.
